Perivinc Pharmaceuticals Private Limited

Perivinc Pharmaceuticals Private Limited - pharma in Tal Viramgam, Gujarat, India. FY 2026 financials & compliance.
CIN U24230GJ2010PTC062038 Incorporated 19 August 2010 ROC Ahmedabad HQ Tal Viramgam, Gujarat, India
Active Private Limited Company pharma
Revenue · FY 2025
₹4.83 Cr
▲ 23% YoY
Net loss · FY 2025
₹2.66 Lakh
Net margin -0.6%
EBITDA · FY 2025
₹87.45 Lakh
EBITDA margin 18.1%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹3.94 Cr
Issued & subscribed
Open charges
₹2 Cr
Satisfied ₹7 Cr
Company age
16 yrs
Est. 2010
Directors on board
4
As per MCA filings

About Perivinc Pharmaceuticals Private Limited

Data last updated:

Perivinc Pharmaceuticals Private Limited is a private limited company based in Tal Viramgam, Gujarat, India, a subsidiary of Yashica Pharmaceuticals Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 August 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2010PTC062038. Its GSTIN is 24AAFCP6352G1ZH (Gujarat).

The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.94 Cr. It is led by directors including Sanjay Patel and Sanjay Khandu Totare.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 257 GIDC Viramgam (Hansalpur), Tal Viramgam, Gujarat, India – 382150.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.83 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net loss of ₹2.66 Lakh (net margin -0.6%) and EBITDA of ₹87.45 Lakh (EBITDA margin 18.1%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 18% over five years.

As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹7 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24230GJ2010PTC062038
Registration Number 062038
Incorporation Date 19 August 2010
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Parent Company Yashica Pharmaceuticals Private Limited
Compliance Status Active Compliant

Contact details

Perivinc Pharmaceuticals Private Limited's registered office is in Tal Viramgam, Gujarat. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No. 257 GIDC Viramgam (Hansalpur), Tal Viramgam, Gujarat, India – 382150
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Perivinc Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Perivinc Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Perivinc Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Perivinc Pharmaceuticals Private Limited, buy the company report.

Financials of Perivinc Pharmaceuticals Private Limited

FY 2024 filings available

Perivinc Pharmaceuticals Private Limited reported revenue of ₹4.83 Cr (up 23% YoY) for FY 2025.

Revenue · FY 2025
₹4.83 Cr ▲ 23%
Net loss · FY 2025
₹2.66 Lakh margin -0.6%
EBITDA · FY 2025
₹87.45 Lakh margin 18.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 38%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 57%
5 years · compounded
▲ 33%

Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 23% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹87.45 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.66 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin18.1%
Net Profit Margin-0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Perivinc Pharmaceuticals Private Limited, buy the company report.

Board of directors of Perivinc Pharmaceuticals Private Limited

Perivinc Pharmaceuticals has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sanjay PatelDirector16 Apr 20197 Years 7 MonthsCurrent
Sanjay Khandu TotareDirector06 Mar 20188 Years 8 MonthsCurrent
Vaishali Sanjay TotareDirector06 Mar 20188 Years 8 MonthsCurrent
Patel Anilkumar SankabhaiDirector16 Apr 20197 Years 7 MonthsCurrent

Auditor

Perivinc Pharmaceuticals Private Limited is audited by MADAN ACHWAL & CO for the financial year 2021.

Auditor firmFinancial yearFirm registration number
MADAN ACHWAL & COFY 2021105693W

Shareholding

The shareholding of Perivinc Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Perivinc Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹2 Cr
Satisfied charges
₹7 Cr
Breakdown by lending institutions
Axis Bank Limited₹2.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
01 Feb 2023100688899Axis Bank Limited₹2 CrOpen
18 May 201310432806Bank of India₹3.5 CrSatisfied
11 May 201310432803Bank of India₹3.5 CrSatisfied

To see the full charge records of Perivinc Pharmaceuticals Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Perivinc Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Perivinc Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAFCP6352G1ZHGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Perivinc Pharmaceuticals Private Limited, buy the company report.

Recent activity

Perivinc Pharmaceuticals Private Limited has 15 board changes on record since 2018: 4 appointments and 11 cessations. The latest: Patel Anilkumar Sankabhai ceased to be Additional Director on 30 Sep 2019.

AGM
Perivinc Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Perivinc Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
A charge with Axis Bank Limited amounted to Rs. 2.00 Cr with Charge ID 100688899 was registered on 01 Feb 2023.
Ceased
Patel Anilkumar Sankabhai ceased to be Additional Director.
Ceased
Sanjay Patel ceased to be Additional Director.
Appointed
Patel Anilkumar Sankabhai was appointed as Director.
Appointed
Sanjay Patel was appointed as Director.
Ceased
Hasmukhbhai Patel ceased to be Director.
Ceased
Sanjay Khandu Totare ceased to be Additional Director.
Ceased
Vaishali Sanjay Totare ceased to be Additional Director.
Ceased
Maganlal Lalgibhai Patel ceased to be Director.
Ceased
Manshokhbhai Kanjibhai Patel ceased to be Director.

11 earlier events are in the company report.

Frequently asked questions

Perivinc Pharmaceuticals is an active private limited company based in Tal Viramgam, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 August 2010 (16+ years old) and is registered under CIN U24230GJ2010PTC062038.

Perivinc Pharmaceuticals has 4 current directors:

The latest financial statements of Perivinc Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Perivinc Pharmaceuticals is 24AAFCP6352G1ZH, registered in Gujarat.

The CIN (Corporate Identification Number) of Perivinc Pharmaceuticals is U24230GJ2010PTC062038. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Perivinc Pharmaceuticals was incorporated on 19 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Patel Anilkumar Sankabhai ceased to be Additional Director on 30 Sep 2019. Sanjay Patel ceased to be Additional Director on 30 Sep 2019. Patel Anilkumar Sankabhai was appointed as Director on 16 Apr 2019. Perivinc Pharmaceuticals has 15 board changes on record in total.

The registered office of Perivinc Pharmaceuticals is at Plot No. 257 GIDC Viramgam Hansalpur, Tal Viramgam, Gujarat, India – 382150.

Perivinc Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

Perivinc Pharmaceuticals has open charges of ₹2 Cr and satisfied charges of ₹7 Cr as per latest MCA filings.